Magnetic source imaging developer Biomagnetic Technologies received some good news with the announcement that Sumitomo Metal Industries, BTI's Japanese distributor, has received approval from the Japanese Ministry of Health and Welfare of BTI's Magnes
Magnetic source imaging developer Biomagnetic Technologies received some good news with the announcement that Sumitomo Metal Industries, BTI's Japanese distributor, has received approval from the Japanese Ministry of Health and Welfare of BTI's Magnes 2500 WH neuromagnetometer for clinical use in Japan. The approval should provide a boost to BTI, which has endured a rough start this year. In March, its stock was delisted from the NASDAQ stock exchange (SCAN 3/19/97). Earlier, the company posted a $2.1 million loss in the first quarter of 1997.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.